Related Experiment Video
Updated: Jan 4, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Deficient Resident Memory T Cell and CD8 T Cell Response to Commensals in Inflammatory Bowel Disease
Alistair Noble1,2, Lydia Durant2, Lesley Hoyles3,4
1Gut Microbes and Health Programme, Quadram Institute Bioscience, Norwich, UK.
Inflammatory bowel disease [IBD] disrupts immune balance, reducing protective T cell responses while increasing antibody production. Restoring T cell immunity may improve gut health and barrier function.
Area of Science:
- Immunology
- Gastroenterology
- Microbiome research
Background:
- The gut microbiota interacts closely with resident memory lymphocytes in mucosal tissues.
- Understanding immune responses to the microbiota is crucial for distinguishing health from inflammatory bowel disease (IBD).
Purpose of the Study:
- To investigate differences in acquired cellular and humoral immunity to the microbiota in healthy individuals versus those with IBD.
- To analyze resident memory T cells (Trm) and local antibody responses in the colon.
Main Methods:
- Analysis of colonic biopsies for resident memory T cells (Trm).
- Assessment of local antibody responses to intraepithelial microbes.
- Evaluation of systemic antigen-specific T and B cell memory to commensal microbes.
Main Results:
- Healthy individuals exhibit systemic CD4 and some CD8 T cell responses to gut bacteria, with limited B cell memory.
- IBD patients show decreased CD8 T cell responses but increased B cell responses and plasmablasts.
- IBD is associated with reduced mucosal CD8+ Trm and γδ T cells, alongside increased IgA responses to intraepithelial bacteria.
- Colonic Trm express CD39 and CD73, indicating regulatory function, and their interaction with dendritic cells influences T-bet expression.
Conclusions:
- IBD presents an imbalance between cellular and humoral immunity, characterized by diminished T cell-mediated barrier immunity and heightened antibody responses.
- The regulatory function of Trm may be linked to intestinal health.
- Strategies promoting Trm and their interaction with dendritic cells, rather than immunosuppression, could enhance tissue immunity and barrier function in IBD.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Cell-mediated Immune Responses
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

